CEO Today Global Awards

CEO Today Global Awards 2020 CANADA 71 www.ceotodaymagazine.com JOSEPH C. PAPA Chairman of the Board and Chief Executive Off icer of Bausch Health Companies Inc. Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global, diverse company with a focus primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company manufactures and markets a broad range of branded and general prescription medicines, over-the-counter health products and medical devices, such as contact lenses, ophthalmic surgical equipment and aesthetics devices. With a large geographic footprint, Bausch Health operates in approximately 100 countries around the world. Bausch Health’s 21,000 employees are united around the company’s mission to improve people’s lives with its health care products, which was set forth by Mr. Papa when he joined the company in 2016 as chairman and chief executive officer. In 2017 under Mr. Papa’s leadership, Bausch Health established the Bausch Foundation to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes around the world. Since its inception, the Bausch Foundation has contributed millions of dollars’ worth of financial and product donations to global charitable health organizations. Mr. Papa has more than 35 years of experience in the pharmaceutical, health care and specialty pharmaceutical industries, including 20 years of branded prescription drug experience. Prior to joining Bausch Health, he was the chief executive officer of the Perrigo Company from 2006 to April 2016. Before that, Mr. Papa served as chairman and chief executive officer of Cardinal Health’s Pharmaceutical Technologies and Services business unit (2004 – 2006). He was president and chief operating officer for Watson Pharmaceuticals (2001 – 2004), president of Global Country Operations for Pharmacia’s North American business (2000 – 2001) and president of Searle’s U.S. Operations (1997 – 2000). Prior to Searle/Pharmacia, Mr. Papa served in a variety of general management, sales, marketing and R&D positions during his 15-year career at Novartis Pharmaceuticals Corporation (1983 – 1997). During his career, he led teams that successfully launched several blockbuster pharmaceutical products, including Lotrel, Diovan and Celebrex, and he is the patent holder for a cardiovascular combination treatment containing Amlodipine and Benazepril. In October 2014, Harvard Business Review ranked Mr. Papa 47th on its “2014 Best Performing CEOs in the World.” He was also recognized on Israel-based Calcalist Magazine’s “Best Chief Executive Officer for the Year” list for 2013 and 2014. Additionally, Mr. Papa was named one of the World’s Best CEOs by Barron’s magazine in 2012, which noted Perrigo “generated one of the best shareholder returns in the S&P 500 in the past five years.” He is a past member of the UConn Foundation Board of Directors and the Smith & Nephew Board of Directors, where he served as chairman of the Remuneration Committee. Mr. Papa holds a B.S. in pharmacy from the University of Connecticut and an MBA from Northwestern University’s Kellogg Graduate School of Management. In 2012, he received an Honorary Doctor of Science degree from the University of Connecticut’s School of Pharmacy. www.bauschhealth.com “Every day, more than 150 million people around the world use a Bausch Health product. As a company dedicated to innovation and advancing global health, I’m proud of the progress we are making in achieving our goals and of our enduring commitment to help people around the world live longer, healthier and more productive lives.” - Joseph C. Papa